Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes
Main Filters
Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes
ALFA WASSERMANN, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
RX2011 | 0 | - | ||
SA2011 | 0 | - |
Beckman Coulter, Inc. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
442635 | 0 | - | ||
467830 | 0 | - | ||
476836 | 0 | - | ||
OSR6179 | 0 | - | ||
OSR6279 | 0 | - |
CAROLINA LIQUID CHEMISTRIES CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
AU-207 | 0 | - | ||
BL207 | 0 | - | ||
CC207 | 0 | - | ||
CC692 | 0 | - | ||
DT207 | 0 | - | ||
ST207 | 0 | - |
CLEARCHEM DIAGNOSTICS INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
CPK1110 | 0 | - |
CLINICAL DIAGNOSTIC SOLUTIONS, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
501-408 | 0 | - |
DREW SCIENTIFIC, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
CPK2-120 | 0 | - | ||
CPK2-1L | 0 | - | ||
DG-CPK2-120 | 0 | - | ||
XL-CPK2-40 | 0 | - |
Fisher Diagnostics | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
TR14010 | 0 | - |
GENCHEM INC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
GEN-CK R1 | 0 | - | ||
GEN-CK R2 | 0 | - |
HORIBA ABX SAS | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
1220001632 | 0 | - | ||
1300023841 | 0 | - |
INFRARED LABORATORY SYSTEMS LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
UV310-1200 | 0 | - | ||
UV310-R | 0 | - | ||
UV310-WK | 0 | - | ||
UV310-X | 0 | - | ||
UV311A-L | 0 | - | ||
UV311B-L | 0 | - | ||
UV312A-L | 0 | - | ||
UV312B-L | 0 | - |
POINTE SCIENTIFIC, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
16-C7522-225 | 0 | - |
RANDOX LABORATORIES LIMITED | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
CK110 | 0 | - | ||
CK113 | 0 | - | ||
CK1212 | 0 | - | ||
CK1296 | 0 | - | ||
CK1553 | 0 | - | ||
CK2813 | 0 | - | ||
CK335 | 0 | - | ||
CK3812 | 0 | - | ||
CK3878 | 0 | - | ||
CK4043 | 0 | - | ||
CK522 | 0 | - | ||
CK7947 | 0 | - |
Roche Diagnostics GmbH | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
12132672216 | 0 | - | ||
4580591190 | 0 | - | ||
4580613190 | 0 | - |
Siemens Healthcare Diagnostics Inc. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
DF32 | 0 | - | ||
K2038 | 0 | - |
84 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatine Kinase Reagent 2 X 60 mL + 1 X 60 mL + 3 wedges
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatinine Kinase Enzyme/Coenzyme 6 X powder vials
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatinine Kinase Enzyme/Coenzyme Diluent 6 X 1000 mL
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatine Kinase Reagent 3 X 25 mL + 3 X 12.5 mL + 3 wedges
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatine Kinase Reagent 1 X 60 mL/1 vial + 1 X 27 mL/1 vial
0
-
Synermed®
INFRARED LABORATORY SYSTEMS LLC
Creatine Kinase Reagent 3 X 60 mL/3 vials + 3 X 27 mL/3 vials
0
-
CK-MB
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.
0
-
CK-NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase activity in serum or plasma.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
CK
RANDOX LABORATORIES LIMITED
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum or plasma.
0
-
CK-MB
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.
0
-
CK-MB
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of CK-MB concentration in serum or plasma.
0
-
CK-MB CONTROL
RANDOX LABORATORIES LIMITED
The device is intended for use in the quality control of CK-MB assays on clinical chemistry systems.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
CK NAC
RANDOX LABORATORIES LIMITED
The device is intended for the quantitative in vitro determination of creatine kinase in serum or plasma.
0
-
ClearChem Diagnostics Inc. Creatine Kinase (CK)
CLEARCHEM DIAGNOSTICS INC.
In Vitro Diagnostics testing kit R1:3X60mL, R2:3X15mL
0
-
Dimension Vista® Flex® reagent cartridge CKI
Siemens Healthcare Diagnostics Inc.
Creatine Kinase Flex® reagent cartridge, 800 Tests
0
-
Dimension® Flex® reagent cartridge MBI
Siemens Healthcare Diagnostics Inc.
Creatine Kinase MB Flex® reagent cartridge, 120 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.® CK REAGENT PRODUCT NO. DT207
CAROLINA LIQUID CHEMISTRIES CORPORATION
CK (Creatine Kinase) 4 x 300 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.® CKMB CC692
CAROLINA LIQUID CHEMISTRIES CORPORATION
CKMB 2 x 60 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.™ CK CREATINE KINASE REAGENT CC207
CAROLINA LIQUID CHEMISTRIES CORPORATION
CK (Creatine Kinase) 2 x 200 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.® CK RGT. KIT AU-207
CAROLINA LIQUID CHEMISTRIES CORPORATION
CK (Creatine Kinase) 3 x 250 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.® CK RGT. KIT BL-207
CAROLINA LIQUID CHEMISTRIES CORPORATION
CK (Creatine Kinase) 3 x 100 tests
0
-
CAROLINA LIQUID CHEMISTRIES CORP.® CLC720 CK RGT KIT Product No. ST207
CAROLINA LIQUID CHEMISTRIES CORPORATION
CK (Creatine Kinase) 4 x 300 tests
0
-
CK-NAC Reagent Set
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
For the quantitative determination of creatine kinase activity in serum. Serum creatinine kinase (CK) levels have proven valuable in the assessment of cardiac and skeletal muscle diseases, including myocardial infarction and muscular dystrophy.¹ Determination of creatine kinase and lactate dehydrogenase isoenzymes provides a definitive diagnosis of acute myocardial infarction.
0
-
Pointe Creatine Kinase Reagent
POINTE SCIENTIFIC, INC.
Pointe Creatine Kinase Reagent packaged for use on the Mindray BA800. 3 x 60ml R1, 3 x 15ml R2. For the quantitative determination of creatine kinase activity in serum.
- 1
- 2